The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Sanofi's 2013 sales performance.
Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the European Commission as the first and only targeted medicine for eosinophilic oesophagitis (EoE), the companies announced. ... Naimish Patel, head of global development, immunology and
Sanofi and Regeneron’s Dupixent (dupilumab) has been recommended for use in the EU to treat severe atopic dermatitis in children aged six months to five years who are candidates for
AstraZeneca and Sanofi’s antibody treatment Beyfortus (nirsevimab) received European Commission approval in November 2022 to prevent RSV in newborns and infants and is currently under review by the FDA.
Eli Lilly, Novo Nordisk and Sanofi produce over 90% of the global insulin supply. ... Eli Lilly, Novo Nordisk and Sanofi produce over 90% of the global insulin supply and the PBMs CVS Caremark, Express Scripts and OptumRx administer pharmacy benefits for
Under the expanded collaboration, Sanofi will have the option to add up to two additional ANKET targets. ... highly synergistic with Sanofi’s allogeneic NK cell platform, engineered lymphokines that stimulate NK cells and growing Immuno-oncology
Hello. We are the Total Health creative agency. It’s our collective mix of talent that gets us to truly different...